Allogeneic Hematopoietic Stem Cell Transplantation
NCT00750126
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumors
Hematologic Neoplasms
Interventions
DRUG:
Fludarabine, Busulfan, Thymoglobulin
Sponsor
University Hospital, Clermont-Ferrand